Original Research

Page 106

Recently published articles about Original Research

Original Research

Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

September 25, 2014

Henrik Lublin, Bjørn H. Ebdrup, Filip K. Knop, et al

Original Research

Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder

September 25, 2014

Peter de Jonge, Klaas J. Wardenaar, Henk Jan Conradi, et al

Original Research

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

September 16, 2014

David Mischoulon, Andrew A. Nierenberg, Mark Hyman Rapaport, et al

Original Research

Group Treatment for Trichotillomania: Cognitive-Behavioral Therapy Versus Supportive Therapy

September 16, 2014

Edson Luiz Toledo, Enilde De Togni Muniz, Antônio Marcelo Cabrita Brito, et al

Original Research

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

September 16, 2014

Philip G. Janicak, David L. Dunner, Linda L. Carpenter, et al

Original Research

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

September 2, 2014

James W. Murrough, Andrew M. Perez, Sanjay J. Mathew, et al

Original Research

Combining Serum Protein Concentrations to Diagnose Schizophrenia: A Preliminary Exploration

August 26, 2014

Peng Xiong, Yong Zeng, Qiuxia Wu, et al

Original Research

Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults

August 26, 2014

Benoit H. Mulsant, Eric J. Lenze, Jordan F. Karp, et al

Original Research

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

August 19, 2014

Robert D. McQuade, Na Jin, William H. Carson, et al

Original Research

Effectiveness of Integrated Care Including Therapeutic Assertive Community Treatment in Severe Schizophrenia Spectrum and Bipolar I Disorders: The 24-Month Follow-Up ACCESS II Study

August 19, 2014

Martin Lambert, Thomas Bock, Daniel Schöttle, et al

Original Research

Venlafaxine and O-Desmethylvenlafaxine Concentrations in Plasma and Cerebrospinal Fluid

August 19, 2014

Christoph Hiemke, Gerhard Gründer, Michael Paulzen, et al

Original Research

Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study

August 5, 2014

Ramin Mojtabai, Yoichiro Takayanagi, Adam P. Spira, et al

« 1 … 104 105 106 107 108 … 328 »

Original Research

Recently published articles about Original Research

Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

Group Treatment for Trichotillomania: Cognitive-Behavioral Therapy Versus Supportive Therapy

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

ELSEWHERE:

FOLLOW US:

Original Research

Recently published articles about Original Research

Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

Group Treatment for Trichotillomania: Cognitive-Behavioral Therapy Versus Supportive Therapy

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

Combining Serum Protein Concentrations to Diagnose Schizophrenia: A Preliminary Exploration

Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Effectiveness of Integrated Care Including Therapeutic Assertive Community Treatment in Severe Schizophrenia Spectrum and Bipolar I Disorders: The 24-Month Follow-Up ACCESS II Study

Venlafaxine and O-Desmethylvenlafaxine Concentrations in Plasma and Cerebrospinal Fluid

Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles